Karuna Positive Results on Phase 3 EMERGENT-3 Trial of KarXT
CenExel is proud to announce that the work of David Walling, PhD, CEO and Principal Investigator at CenExel CNS, joined lead author, John H Krystal, as co-author of the
View More Validation of a suite of ERP and QEEG biomarkers
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry led-study in subjects with schizophrenia and healthy volunteers.
View More Females with Schizophrenia for Clinical Trials
Are you a woman living with schizophrenia? We have several clinical trials that might be just right for you. The trials are compensated if you qualify, and transportation is
View More
